Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05899790 |
Other study ID # |
Eastern MU-SBF-HB-SÇP-01 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 29, 2022 |
Est. completion date |
December 15, 2022 |
Study information
Verified date |
June 2023 |
Source |
Eastern Mediterranean University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Virtual Reality (VR) applications, one of the commonly emphasized approaches in the medical
field recently, is in place as an intervention method applicable in various fileds of
medicine for distraction, experiencing being exposed to events creating stress and palliating
anxiety through providing materials which may distract the patient's attention from a
stressful condition. The study has been planned in order to evaluate the effect of the
notification regarding the theatre environment through virtual reality to the patients, who
are to go through abdominal surgical intervention, on the anxiety level and the vital signs
during the surgical intervention.
Being a non-pharmacological clinical randomize controlled one, the study shall be conducted
in Dr. Burhan Nalbantoğlu State Hospital of TRNC Ministry of Health surgical service and
preoperative waiting area.
Sample number has been determined through power analysis using G*Power 3.1.9.2 software.
Taking (2017) "The effect of virtual reality in reducing preoperative anxiety in patients
prior to arthroscopic knee surgery: A randomised controlled trial" study of Robertson and
friends as the reference, the effect size, regarding the anxiety scores of experiment and
control groups participants, has been determined as 0,63. Accordingly, sample size has been
calculated as 71 people necessary for 95% (1-β=0,95) power at d=0,63 and α=0,05 levels.
Taking into account there may be losses during the study, it has been planned to involve 80
people, so as to have 40 people per each group, in the study.
Since the patients, who are to be involved in the study, are not known; in order to assign
same quantity of patients to each group prior to the study, randomization shall be done
through using block randomization technique in GraphPad software so as to have 40 patients in
the intervention group and 40 in the control group. The patients who receive standard
clinical care prior to abdominal surgical intervention shall constitute the control group,
the patients who receive information about operating room environment through VR goggles in
addition to standard clinical care shall constitute the intervention group. The data shall be
collected through "Individual characteristics Form", ''Patient Charts'', ''Surgical Anxiety
Scale'', ''Galvanic Skin Sensor (GSS) Measurement Table''.
SPSS 26 Statistical analysis program shall be used for evaluating the study data. The
acquired data shall be tested at 95% confidence interval, p<0,05 level of significance.
Number, percentage distributon and standard deviation for the definitive data analysis, chi
square test for experiment and control groups' basic particulars similarity, Shapiro-Wilk for
normality analysis of dependent variables, Student t test or Annova for the comparison of
pre-test and final test scores of experiment control groups, the comparisons of variables
giving normal distribution among the groups as per the normal distributon in the comparison
of experiment control groups' pre-test and final test scores, Mann Whitney U test or Kruskal
Wallis test for the variables of non-normal distribution shall be used.
Description:
Surgical interventions, which are widely used for health improvement and disease treatment,
are one of the most important experiences in an individual's life. Surgical interventions,
regardless of simple or life threatening, turn in to a condition leading to individual's loss
of control on his body for a limited time and anxiety due to not having sufficient
information about the subject although they are positive things which would provide recovery
from illness. It is known that more medical complications build up in patients who have
higher level of anxiety during the medical process. Although the factors, which trigger the
anxiety, vary significantly among the individuals, the effects of common or lasting anxiety
cases are usually similar. These factors may lead to effects such as pain, sinus tachycardia,
hypertension, cardiac arrhythmia, surgical interventions, increase in anesthesia and
analgesia necessities, latency in wound healing and discharge periods. Operating rooms being
complex and unusual environments and getting anesthesia lead to anxiety and fear in patients.
Since focusing on pharmacological intervetions in the current management of anxiety increases
complications, which may build up inthe patient; easy to use, noninvasive non-pharmacological
applications are required. Virtual Reality (VR) applications, one of the commonly emphasized
approaches in the medical field recently, is in place as an intervention method applicable in
various fileds of medicine for distraction, experiencing being exposed to events creating
stress and palliating anxiety through providing materials which may distract the patient's
attention from a stressful condition. The study has been planned in order to evaluate the
effect of the notification regarding the theatre environment through virtual reality to the
patients, who are to go through abdominal surgical intervention, on the anxiety level and the
vital signs during the surgical intervention.
Being a non-pharmacological clinical randomize controlled one, the study shall be conducted
in Dr. Burhan Nalbantoğlu State Hospital of TRNC Ministry of Health surgical service and
preoperative waiting area. The criteria for being involved in the study have been defined as
patients who are of 18 years old and over, are to go through abdominal surgical intervention,
are conscious, have orientation of place-person and time, do not have any visual, audial or
mental problem, have the ability of understanding the instructions of the study and reacting,
can communicate in Turkish and give written approval for participating in the study. The
criteria of being excluded form the study have been defined as the patients who regularly
receive phytotherapy or pharmacotherapy for anxiety, are diagnosed with hypertension, cardiac
arrhythmia, have facial injuries preventing comfortable utilization of VR hardware and are
unpremedicated. The criteria of elimination from the study shall be composed of the patients
who want to quit at own request, can not comply with the study process and conditions.
Sample number has been determined through power analysis using G*Power 3.1.9.2 software.
Taking (2017) "The effect of virtual reality in reducing preoperative anxiety in patients
prior to arthroscopic knee surgery: A randomised controlled trial" study of Robertson and
friends as the reference, the effect size, regarding the anxiety scores of experiment and
control groups participants, has been determined as 0,63. Accordingly, sample size has been
calculated as 71 people necessary for 95% (1-β=0,95) power at d=0,63 and α=0,05 levels.
Taking into account there may be losses during the study, it has been planned to involve 80
people, so as to have 40 people per each group, in the study.
Since the patients, who are to be involved in the study, are not known; in order to assign
same quantity of patients to each group prior to the study, randomization shall be done
through using block randomization technique in GraphPad software so as to have 40 patients in
the intervention group and 40 in the control group. The patients who receive standard
clinical care prior to abdominal surgical intervention shall constitute the control group,
the patients who receive information about operating room environment through VR goggles in
addition to standard clinical care shall constitute the intervention group. The data shall be
collected through "Individual characteristics Form", ''Patient Charts'', ''Surgical Anxiety
Scale'', ''Galvanic Skin Sensor (GSS) Measurement Table''.
SPSS 26 Statistical analysis program shall be used for evaluating the study data. The
acquired data shall be tested at 95% confidence interval, p<0,05 level of significance.
Number, percentage distributon and standard deviation for the definitive data analysis, chi
square test for experiment and control groups' basic particulars similarity, Shapiro-Wilk for
normality analysis of dependent variables, Student t test or Annova for the comparison of
pre-test and final test scores of experiment control groups, the comparisons of variables
giving normal distribution among the groups as per the normal distributon in the comparison
of experiment control groups' pre-test and final test scores, Mann Whitney U test or Kruskal
Wallis test for the variables of non-normal distribution shall be used.